Myriad Genetics Inc (MYGN)

Change in Working Capital

$13.40M

Quarterly · Period ending: · USD

MYGN logo

MYGN Change in Working Capital

Latest reported$13.40M
MYGN Quarterly Change in Working Capital (-$300.00K → $13.40M)
High-resolution chart · PNG

MYGN change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
13,400,000
-8,199,999
-1,600,000
21,400,000
-27,000,000
-12,100,000
-24,200,000
-7,300,000
-2,300,000
-20,600,000
-41,300,000
-6,500,000
99,100,000
-24,300,000
4,700,000
7,400,000
-56,600,000
-57,400,000
-17,100,000
53,100,000
-4,900,000
90,800,000
44,700,000
-135,000,000
97,200,000
23,300,000
-15,600,000
10,200,000
-9,000,000
-23,800,000
10,600,000
-14,900,000
13,400,000
9,000,000
-2,000,000
-13,100,000
-3,500,000
2,700,000
-5,900,000
-29,900,000
-7,500,000
-9,500,000
-26,900,000
-33,900,000
2,523,000
-18,000,000
5,100,000
-30,400,000
-10,542,000
-42,352,000
-20,885,000
13,806,000
1,066,000
-14,934,000
-31,146,000
3,989,000
-148,000
-6,441,000
-18,098,000
-4,079,000
51,744,000
-9,570,000
1,823,000
-5,455,000
-702,000
-2,115,000
-5,528,000
-19,054,000
1,095,000
-31,026,000
7,962,000
-32,174,000
33,052,000
-356,000
-4,230,000
-11,608,000
2,363,000
-4,559,000
-3,258,000
-5,721,000
4,882,000
-701,000
-1,462,000
-4,127,000
6,880,000
-503,000
3,183,000
-3,484,000
1,408,000
4,694,000
1,485,000
-5,643,000
4,247,000
-13,618,000
-3,866,000
-14,105,000
9,679,420
-5,103,462
-2,146,182
-9,713,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.